Soft Drink and Juice Consumption and Renal Cell Carcinoma Incidence and Mortality in the European Prospective Investigation into Cancer and Nutrition
Permanent link
https://hdl.handle.net/10037/24725Date
2021-06-01Type
Journal articleTidsskriftartikkel
Peer reviewed
Author
Heath, Alicia K; Clasen, Johanna L; Jayanth, Nick P; Jenab, Mazda; Tjønneland, Anne; Petersen, Kristina E N; Overvad, Kim; Srour, Bernard; Katzke, Verena; Bergmann, Manuela M; Schulze, Matthias B; Masala, Giovanna; Krogh, Vittorio; Tumino, Rosario; Catalano, A; Pasanisi, Fabrizio; Brustad, Magritt; Olsen, Karina Standahl; Skeie, Guri; Lujan-Barroso, Leila; RodrÍguez-Barranco, Miguel; Amiano, Pilar; Santiuste, Carmen; Gurrea, Aurelio Barricarte; Axelson, Håkon; Ramne, Stina; Ljungberg, Börje; Watts, Eleanor L.; Huybrechts, Inge; Weiderpass, Elisabete; Riboli, Elio; Muller, David CAbstract
Methods: A total of 389,220 EPIC participants with median age of 52 years at recruitment (1991–2000) were included. Cox regression yielded adjusted HRs and 95% confidence intervals (CI) for RCC incidence and mortality in relation to intakes of juices and total, sugar-sweetened, and artificially sweetened soft drinks.
Results: A total of 888 incident RCCs and 356 RCC deaths were identified. In models including adjustment for body mass index and energy intake, there was no higher risk of incident RCC associated with consumption of juices (HR per 100 g/day increment = 1.03; 95% CI, 0.97–1.09), total soft drinks (HR = 1.01; 95% CI, 0.98–1.05), sugar-sweetened soft drinks (HR = 0.99; 95% CI, 0.94–1.05), or artificially sweetened soft drinks (HR = 1.02; 95% CI, 0.96–1.08). In these fully adjusted models, none of the beverages was associated with RCC mortality (HR, 95% CI per 100 g/day increment 1.06, 0.97–1.16; 1.03, 0.98–1.09; 0.97, 0.89–1.07; and 1.06, 0.99–1.14, respectively).
Conclusions: Consumption of juices or soft drinks was not associated with RCC incidence or mortality after adjusting for obesity.
Impact: Soft drink and juice intakes are unlikely to play an independent role in RCC development or mortality.